Clinical Trial Update: Clinical Trial to Assess the Efficacy and Safety of Combination Therapy of Motireb 5/100 mg in Functional Dyspepsia Patients. [Phase 3]

View source ↗

Summary

This is a Phase 3 clinical trial evaluating the efficacy and safety of Motireb 5/100 mg in patients with functional dyspepsia. The trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Functional Dyspepsia

Drugs mentioned

• Motireb

Snippet

Sponsor: IlDong Pharmaceutical Co Ltd | Conditions: Functional Dyspepsia | Phase 3 | Status: UNKNOWN